Yuanbo Hu

925 total citations
35 papers, 590 citations indexed

About

Yuanbo Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuanbo Hu has authored 35 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Yuanbo Hu's work include Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). Yuanbo Hu is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). Yuanbo Hu collaborates with scholars based in China, United States and Italy. Yuanbo Hu's co-authors include Wen Huang, Qianhui Xu, Xian Shen, Chenbin Chen, Xiangyang Xue, Sian Chen, Xinya Tong, Xiangwei Sun, Zhiyuan Chen and Xianjing Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Advanced Functional Materials.

In The Last Decade

Yuanbo Hu

33 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanbo Hu China 13 350 221 133 132 77 35 590
Xiangfu Chen China 16 454 1.3× 231 1.0× 150 1.1× 103 0.8× 57 0.7× 43 705
Priyakshi Kalita‐de Croft Australia 14 360 1.0× 136 0.6× 131 1.0× 112 0.8× 101 1.3× 25 594
Junxiang Wen China 14 285 0.8× 182 0.8× 129 1.0× 149 1.1× 85 1.1× 35 550
Haoyu Lin China 19 505 1.4× 292 1.3× 247 1.9× 173 1.3× 85 1.1× 39 851
Zhi‐Jun Pei China 15 495 1.4× 299 1.4× 127 1.0× 171 1.3× 45 0.6× 51 699
Amit Mandoli Netherlands 10 363 1.0× 135 0.6× 123 0.9× 66 0.5× 47 0.6× 19 607
Hui Qian China 9 341 1.0× 202 0.9× 146 1.1× 46 0.3× 102 1.3× 25 568
Zehao Wang China 11 328 0.9× 212 1.0× 60 0.5× 80 0.6× 56 0.7× 28 525
Berit M. Pfitzner Germany 11 243 0.7× 236 1.1× 262 2.0× 126 1.0× 72 0.9× 26 620
Hecheng Zhu China 14 295 0.8× 157 0.7× 110 0.8× 96 0.7× 132 1.7× 29 530

Countries citing papers authored by Yuanbo Hu

Since Specialization
Citations

This map shows the geographic impact of Yuanbo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanbo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanbo Hu more than expected).

Fields of papers citing papers by Yuanbo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanbo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanbo Hu. The network helps show where Yuanbo Hu may publish in the future.

Co-authorship network of co-authors of Yuanbo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanbo Hu. A scholar is included among the top collaborators of Yuanbo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanbo Hu. Yuanbo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yu, et al.. (2025). A novel pyridine-2-one AMPK inhibitor: Discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model. European Journal of Medicinal Chemistry. 286. 117266–117266. 1 indexed citations
2.
Hu, Yuanbo, Chenbin Chen, Kezhi Lin, et al.. (2025). NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner. Clinical and Translational Medicine. 15(4). e70282–e70282. 2 indexed citations
3.
4.
Ding, Yinghao, Shengyi Zhang, Xiaohong Chen, et al.. (2024). Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy. Nano Letters. 24(24). 7397–7407. 6 indexed citations
5.
Chen, Li, Yuanbo Hu, Bingyu Zhang, et al.. (2024). Integrated multiomics analysis identified comprehensive crosstalk between diverse programmed cell death patterns and novel molecular subtypes in Hepatocellular Carcinoma. Scientific Reports. 14(1). 27529–27529. 6 indexed citations
6.
Han, Zheng, Hua Chen, Juanjuan Huang, et al.. (2023). ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer. Cell Death and Disease. 14(2). 124–124. 15 indexed citations
7.
Li, Mengqi, Yuanbo Hu, Xiaohui Li, et al.. (2023). Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model. Respiratory Research. 24(1). 289–289. 13 indexed citations
8.
Tong, Xinya, Yuanbo Hu, Yingying Hu, et al.. (2022). NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma. Frontiers in Oncology. 12. 788801–788801. 29 indexed citations
9.
Hu, Yuanbo, et al.. (2021). Research on Vehicle Adaptive Cruise Control Method Based on Fuzzy Model Predictive Control. Machines. 9(8). 160–160. 17 indexed citations
10.
11.
Hu, Yuanbo, Chenbin Chen, Xinya Tong, et al.. (2021). NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death and Disease. 12(9). 842–842. 154 indexed citations
12.
Xu, Qianhui, Yuanbo Hu, Siwei Li, et al.. (2021). Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 8. 683240–683240. 13 indexed citations
13.
Xu, Qianhui, et al.. (2021). Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma. Frontiers in Genetics. 12. 739975–739975. 9 indexed citations
14.
Ye, Sisi, Yuanbo Hu, Chenbin Chen, et al.. (2021). The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer. Frontiers in Oncology. 11. 614925–614925. 4 indexed citations
15.
Chen, Sian, Chenbin Chen, Yuanbo Hu, et al.. (2021). Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue. Frontiers in Oncology. 10. 614096–614096. 8 indexed citations
16.
Chen, Xiaohong, Xiang Wang, Ce Zhu, et al.. (2019). <p>Preoperative Hyponatremia And Hypocalcemia Predict Poor Prognosis In Elderly Gastric Cancer Patients</p>. Cancer Management and Research. Volume 11. 8765–8780. 13 indexed citations
17.
Shao, Zhenxuan, Fang Xia, Qingbo Lv, et al.. (2018). Comparison of combined anterior–posterior approach versus posterior-only approach in neuromuscular scoliosis: a systematic review and meta-analysis. European Spine Journal. 27(9). 2213–2222. 9 indexed citations
18.
Hu, Yuanbo, et al.. (2017). [Progress in the regulation of bone remodeling at the cellular level].. PubMed. 34(3). 471–479. 1 indexed citations
19.
Hu, Yuanbo, Xiangyang Wang, Sipin Zhu, et al.. (2017). The Spinal Cord Line Can Predict Postoperative Recovery for Multilevel Cervical Spondylotic Myelopathy. World Neurosurgery. 104. 361–366.
20.
Zhang, Jinjing, Juanjuan Zhu, Yuanbo Hu, et al.. (2017). Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke. Oncotarget. 8(60). 102067–102077. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangfu Chen Breakdown of academic impact, for papers by Priyakshi Kalita‐de Croft Breakdown of academic impact, for papers by Junxiang Wen Breakdown of academic impact, for papers by Haoyu Lin Breakdown of academic impact, for papers by Zhi‐Jun Pei Breakdown of academic impact, for papers by Amit Mandoli Breakdown of academic impact, for papers by Hui Qian Breakdown of academic impact, for papers by Zehao Wang Breakdown of academic impact, for papers by Berit M. Pfitzner Breakdown of academic impact, for papers by Hecheng Zhu
Rankless by CCL
2026